With a Ph.D. in Chemical Engineering from Texas A&M University and accolades such as the Outstanding Researcher Award by Women in Science and Engineering, I specialize in pioneering research at the intersection of biotechnology and innovation. My expertise lies in developing cutting-edge 3D-printed vascularized organ models for drug screening, integrating AI for enhanced phenotyping, and securing strategic partnerships. Notably, at Systemic Bio, I led the development of vascularized tumor-on-a-chip assays, securing the startup's first partnership with a top-tier pharmaceutical company. My research on cellular evolution and cancer mechanobiology has garnered international recognition, with high-impact publications and best presenter awards at conferences. As a Global Consulting Fellow at Blue Chapter, I developed strategic go-to-market strategies for AI-driven marketing solutions, showcasing my ability to translate technical expertise into actionable business strategies. Committed to community engagement, I actively mentor students and engage in cultural initiatives. Overall, my multifaceted experiences and dedication to innovation position me as a dynamic leader ready to drive impactful advancements in biotechnology and beyond.